These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22712283)

  • 1. [The analysis of amount of matrix metalloproteinase 1 precursor, metalloproteinase 1 tissue inhibitor and cystatin C in the bronchoalveolar secretion of patients with nonspecific lung diseases].
    Koretskaia NA; Vavilova TP; Tkachev GA
    Klin Lab Diagn; 2012 Mar; (3):10-3. PubMed ID: 22712283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the thickness of bronchial wall layers, emphysema score, and markers of remodeling in bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease.
    Górka K; Soja J; Jakieła B; Plutecka H; Gross-Sondej I; Ćmiel A; Mikrut S; Łoboda P; Andrychiewicz A; Jurek P; Sładek K
    Pol Arch Med Wewn; 2016 Jun; 126(6):402-10. PubMed ID: 27362393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
    Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
    Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease.
    Sweet DG; McMahon KJ; Curley AE; O'Connor CM; Halliday HL
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F168-71. PubMed ID: 11320042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 and its inhibitor in idiopathic pulmonary hemosiderosis.
    Tang LF; Huang XY; Chen ZM; Du LZ
    Indian J Pediatr; 2010 May; 77(5):581-2. PubMed ID: 20140773
    [No Abstract]   [Full Text] [Related]  

  • 6. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma.
    Tanaka H; Miyazaki N; Oashi K; Tanaka S; Ohmichi M; Abe S
    J Allergy Clin Immunol; 2000 May; 105(5):900-5. PubMed ID: 10808169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia.
    Choi KH; Lee HB; Jeong MY; Rhee YK; Chung MJ; Kwak YG; Lee YC
    Chest; 2002 May; 121(5):1478-85. PubMed ID: 12006432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.
    Lemjabbar H; Gosset P; Lamblin C; Tillie I; Hartmann D; Wallaert B; Tonnel AB; Lafuma C
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1298-307. PubMed ID: 10194181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased matrix metalloproteinase-9 in the airway after allergen challenge.
    Kelly EA; Busse WW; Jarjour NN
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1157-61. PubMed ID: 10988146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio.
    Doherty GM; Kamath SV; de Courcey F; Christie SN; Chisakuta A; Lyons JD; Heaney LG; Ennis M; Shields MD
    Clin Exp Allergy; 2005 Sep; 35(9):1168-74. PubMed ID: 16164443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
    Tüter G; Kurtiş B; Serdar M
    J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics: is it an approach to understand the progression of chronic lung disorders?
    Sepper R; Prikk K
    J Proteome Res; 2004; 3(2):277-81. PubMed ID: 15113104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between expression of matrix metalloproteinase-9 and adenylyl cyclase-associated protein 1 in chronic obstructive pulmonary disease.
    Xie SS; Hu F; Tan M; Duan YX; Song XL; Wang CH
    J Int Med Res; 2014 Dec; 42(6):1272-84. PubMed ID: 25332229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
    Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion.
    Ko FW; Diba C; Roth M; McKay K; Johnson PR; Salome C; King GG
    Chest; 2005 Jun; 127(6):1919-27. PubMed ID: 15947303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of sTREM-1, IL-6 and IL-13 concentration in bronchoalveolar lavage fluid in asthma and COPD: A preliminary study.
    Proboszcz M; Paplińska-Goryca M; Nejman-Gryz P; Górska K; Krenke R
    Adv Clin Exp Med; 2017; 26(2):231-236. PubMed ID: 28791839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9 (MMP-9) and up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) in human bronchoalveolar lavage cells.
    Frankenberger M; Hauck RW; Frankenberger B; Häussinger K; Maier KL; Heyder J; Ziegler-Heitbrock HW
    Mol Med; 2001 Apr; 7(4):263-70. PubMed ID: 11471571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids.
    Mattos W; Lim S; Russell R; Jatakanon A; Chung KF; Barnes PJ
    Chest; 2002 Nov; 122(5):1543-52. PubMed ID: 12426251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma.
    Kumagai K; Ohno I; Okada S; Ohkawara Y; Suzuki K; Shinya T; Nagase H; Iwata K; Shirato K
    J Immunol; 1999 Apr; 162(7):4212-9. PubMed ID: 10201949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.